SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-069194
Filing Date
2024-06-06
Accepted
2024-06-06 20:29:42
Documents
1
Group Members
BIOXCEL HOLDINGS, INC.VIMAL MEHTA

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2416681d1_sc13da.htm SC 13D/A 70555
  Complete submission text file 0001104659-24-069194.txt   72329
Mailing Address 2614 BOSTON POST ROAD SUITE #33B GUILFORD CT 06437
Business Address 2614 BOSTON POST ROAD SUITE #33B GUILFORD CT 06437 203-643-8002
BioXcel LLC (Filed by) CIK: 0001651990 (see all company filings)

IRS No.: 202612128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90437 | Film No.: 241026985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)